- Home
- BUSE vs OCUL Comparison
BUSE vs OCUL Comparison
Compare BUSE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- OCUL
- Stock Information
- Founded
- BUSE 1868
- OCUL 2006
- Country
- BUSE United States
- OCUL United States
- Employees
- BUSE N/A
- OCUL N/A
- Industry
- BUSE Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- OCUL Health Care
- Exchange
- BUSE Nasdaq
- OCUL Nasdaq
- Market Cap
- BUSE 1.5B
- OCUL 1.4B
- IPO Year
- BUSE N/A
- OCUL 2014
- Fundamental
- Price
- BUSE $23.20
- OCUL $8.09
- Analyst Decision
- BUSE Hold
- OCUL Strong Buy
- Analyst Count
- BUSE 3
- OCUL 8
- Target Price
- BUSE $30.00
- OCUL $16.50
- AVG Volume (30 Days)
- BUSE 264.6K
- OCUL 842.8K
- Earning Date
- BUSE 01-28-2025
- OCUL 03-10-2025
- Dividend Yield
- BUSE 4.13%
- OCUL N/A
- EPS Growth
- BUSE N/A
- OCUL N/A
- EPS
- BUSE 1.95
- OCUL N/A
- Revenue
- BUSE $446,371,000.00
- OCUL $61,442,000.00
- Revenue This Year
- BUSE N/A
- OCUL $11.40
- Revenue Next Year
- BUSE $55.56
- OCUL $13.58
- P/E Ratio
- BUSE $11.95
- OCUL N/A
- Revenue Growth
- BUSE N/A
- OCUL 6.45
- 52 Week Low
- BUSE $21.59
- OCUL $3.92
- 52 Week High
- BUSE $28.97
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- BUSE 41.94
- OCUL 40.09
- Support Level
- BUSE $22.55
- OCUL $7.99
- Resistance Level
- BUSE $23.45
- OCUL $8.43
- Average True Range (ATR)
- BUSE 0.63
- OCUL 0.38
- MACD
- BUSE 0.11
- OCUL -0.02
- Stochastic Oscillator
- BUSE 47.92
- OCUL 25.90
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.